Rapaccini, Gian Ludovico
 Distribuzione geografica
Continente #
EU - Europa 6.162
NA - Nord America 4.969
AS - Asia 1.031
AF - Africa 44
Continente sconosciuto - Info sul continente non disponibili 20
SA - Sud America 19
OC - Oceania 12
Totale 12.257
Nazione #
US - Stati Uniti d'America 4.943
DE - Germania 2.446
SE - Svezia 1.312
CN - Cina 750
UA - Ucraina 568
IE - Irlanda 449
IT - Italia 430
FR - Francia 276
GB - Regno Unito 209
FI - Finlandia 169
BE - Belgio 133
TR - Turchia 112
IN - India 86
PL - Polonia 64
CI - Costa d'Avorio 35
JP - Giappone 31
IR - Iran 18
RU - Federazione Russa 18
NL - Olanda 17
EU - Europa 16
VN - Vietnam 14
BZ - Belize 13
RO - Romania 13
CA - Canada 12
AU - Australia 9
BR - Brasile 9
CH - Svizzera 8
ES - Italia 7
AT - Austria 6
CL - Cile 6
GR - Grecia 6
CZ - Repubblica Ceca 5
DK - Danimarca 5
PT - Portogallo 5
HU - Ungheria 4
HK - Hong Kong 3
NZ - Nuova Zelanda 3
SC - Seychelles 3
A1 - Anonimo 2
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
BY - Bielorussia 2
IL - Israele 2
NO - Norvegia 2
PH - Filippine 2
RE - Reunion 2
SD - Sudan 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
IQ - Iraq 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MM - Myanmar 1
MY - Malesia 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 12.257
Città #
Chandler 1.208
Dublin 448
Jacksonville 320
San Mateo 250
Nanjing 226
Ann Arbor 163
Nürnberg 162
Ashburn 157
Wilmington 156
Boston 142
Dearborn 139
Brussels 131
Houston 128
Princeton 125
Izmir 102
Chicago 100
Marseille 99
Cattolica 87
Woodbridge 79
Nanchang 69
Bremen 61
Helsinki 61
Redwood City 61
Redmond 60
Beijing 59
Munich 55
Fairfield 52
Kraków 52
Seattle 50
Shenyang 46
Milan 42
San Jose 42
Lawrence 41
Hebei 38
Rome 38
Lancaster 36
Abidjan 35
Mountain View 34
Norwalk 33
Tianjin 33
Zhengzhou 31
Kunming 30
University Park 29
Hangzhou 28
Changsha 25
Leawood 24
Augusta 23
Jiaxing 22
Boardman 20
Guangzhou 20
Falls Church 19
Jinan 19
Detroit 18
Edinburgh 17
Las Vegas 17
Shanghai 17
Buffalo 14
Castelnuovo di Val di Cecina 14
Belize City 13
Boydton 13
Hanoi 13
Fremont 12
Hefei 12
Lanzhou 12
Warsaw 12
Andover 11
Cambridge 10
London 10
Tokyo 10
Costa Mesa 9
Kish 9
San Diego 9
Simi Valley 9
Auburn Hills 8
Changchun 8
New York 8
Portland 8
Bologna 7
Cagliari 7
Phoenix 7
Sacramento 7
Taizhou 7
Albuquerque 6
Bern 6
Kocaeli 6
Saint Louis 6
Los Angeles 5
Millbury 5
Ningbo 5
Palermo 5
Paris 5
São Paulo 5
Toronto 5
Vienna 5
Budapest 4
Carignano 4
Decatur 4
Fuzhou 4
Indiana 4
Madrid 4
Totale 5.926
Nome #
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging 371
Association between Klinefelter syndrome and focal nodular hyperplasia 254
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 197
gc) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. 176
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 172
Abdominal angina due to recurrence of cancer of the papilla of vater: a case report. 170
Long term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma <= 3 cm. Results of a multicenter Italian survey. 170
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 153
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 143
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 140
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 136
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 136
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 135
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study 133
Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients. 131
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 130
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants. 127
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study 123
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 122
Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis. 122
Infliximab in Steroid-dependent Ulcerative Colitis: Effectiveness and Predictors of Clinical and Endoscopic Remission. 121
recurrent acute hepatitis associated with use of cetrizine 120
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 116
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 116
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 115
A case of non-occlusive mesenteric ischemia and hepatic portal venous gas: not everyone knows that… 114
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 112
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 110
Potential use of liver function breath tests in the clinical practice. 105
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 99
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 96
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection 94
Evaluation of the albumin-gamma-glutamyl transferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis. 94
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 88
Doppler ultrasonographic evaluation of blood flow in the superior mesenteric artery in celiac patients and in healthy controls in fasting conditions and after saccharose ingestion 88
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year. 88
DNA ploidy pattern in human chronic liver diseases and hepatic nodular lesions. Flow cytometric analysis on echo-guided needle liver biopsy 87
Magnesium Absorption in Intestinal Cells: Evidence of Cross-Talk between EGF and TRPM6 and Novel Implications for Cetuximab Therapy 87
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 86
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 85
Gastric wall thickness in normal and neoplastic subjects: a prospective study performed by abdominal ultrasound 84
[Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients] 83
Lipohyperplasia of the ileocaecal valve as a cause of intestinal haemorrhage: an ultrasound Doppler study 82
Severe Skin Burn at Needle Entry Point Complicating Radiofrequency Ablation for Hepatocellular Carcinoma 82
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study 82
Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases 81
Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma 80
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 80
[Liver transplantation] 79
Single Hepatocellular Carcinoma Smaller than 2 cm: Are Ethanol Injection and Radiofrequency Ablation Equally Effective? 78
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 76
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 75
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing. 75
Liver transplantation in patients with alcoholic liver disease: A retrospective study 75
Amantadine-induced livedo reticularis occurring during treatment of chronic hepatitis C 74
Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. 72
Is coeliac disease a confounding factor in the diagnosis of NASH? 71
Botulinum toxin-B ultrasound-guided injections for sialorrhea in amytrophic lateral sclerosis and Parkinson's disease 71
Liver transplantation in Italy: preliminary 10-year report. The Monotematica Aisf-Olt Study Group 71
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 71
Clinical suspicion of pancreatic neoplasm: does echo-guided fine-needle biopsy modify patient management? 69
Impairment of recent thymic emigrants in HCV infection. 68
Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease. 68
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 68
Contrast-enhanced power doppler of the intestinal wall in the evaluation of patients with Crohn disease 66
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 66
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome 64
Neoplastic seeding complicating percutaneous ethanol injection for treatment of hepatocellular carcinoma 63
Bridge treatments of hepatocellular carcinoma in cirrhotic patients submitted to liver transplantation 62
Gallbladder emptying, plasma levels of estradiol and progesterone, and cholecystokinin secretion in liver cirrhosis 62
Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy 61
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma 61
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing 61
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 61
Immunological role of IgG subclasses 61
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 61
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 61
Cruveilhier-Baumgarten syndrome: an efficient spontaneous portosystemic collateral preventing oesophageal varices bleeding 60
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 60
Primary neoplasm of the duodenum diagnosed by echo-guided fine-needle biopsy 59
Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation 59
Sarilumab use in severe SARS-CoV-2 pneumonia 59
Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk 58
Contrast-enhanced ultrasonography in chronic glomerulonephritides: correlation with histological parameters of disease activity 58
The Laboratory Role in anti-TNF Biological Therapy Era 58
Acute hepatitis associated with use of paroxetine 57
Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel diseases 57
Portal vein thrombosis complicating hepatocellular carcinoma. Value of ultrasound-guided fine-needle biopsy of the thrombus in the therapeutic management 57
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 57
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 57
Long-term effectiveness of Radiofrequency Ablation for solitary small Hepatocellular Carcinoma: A retrospective analysis of 363 patients 56
Ultrasound-guided fine-needle biopsy of hepatocellular carcinoma: comparison between smear cytology and microhistology 55
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 55
Recurrent acute hepatitis associated with use of cetirizine 54
The Italian experience on paediatric liver transplantation: 1988-1999 report 54
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules 54
Early renal involvement in diabetes mellitus: comparison of renal Doppler US and radioisotope evaluation of glomerular hyperfiltration 53
Doppler ultrasonographic evaluation of the early changes in renal resistive index in cirrhotic patients undergoing liver transplantation 53
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 53
Hypoechoic lesions in fatty liver. Quantitative study by histomorphometry 52
Totale 9.182
Categoria #
all - tutte 34.575
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.575


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.112 0 0 27 55 208 134 136 75 102 72 167 136
2019/20201.656 334 103 90 58 144 207 150 82 103 109 139 137
2020/20211.225 67 114 46 141 149 41 115 28 168 58 260 38
2021/20221.642 110 118 39 140 102 54 34 221 66 107 283 368
2022/20233.808 476 436 268 501 296 434 249 318 453 129 169 79
2023/2024803 129 624 50 0 0 0 0 0 0 0 0 0
Totale 12.507